Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Aim/hypothesis This study aimed to investigate if variability in the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with Type II (non-insulin-dependent) diabetes mellitus.Methods The PGC-1 gene was examined in 53 Type II diabetic patients applying single strand conformational polymorphism analysis followed by nucleotide sequencing. Identified variants were genotyped in an association study comprising 483 Type II diabetic patients and 216 glucose-tolerant control subjects. A replication study was done in an additional 201 Type II diabetic patients and 293 glucose-tolerant subjects. Furthermore, a potential interaction between the Pro12Ala polymorphism of PPAR-gamma2 and the PGC-1 Gly482Ser variant on risk of Type II diabetes was investigated.Results A total of seven variants (Ser74Leu, IVS2 + 52C-->A, Thr394Thr, Asp475Asp, Gly482Ser, Thr528Thr, and Thr612Met) were identified and investigated in an association study. Six of the variants showed no association with Type II diabetes in the initial study. However, the Gly482Ser polymorphism, was more frequent among Type II diabetic patients (37.0 %) than among glucose-tolerant subjects (30.8 %) (p = 0.032). In a replication study the difference in allele frequencies of the Gly482Ser variant remained significant (p = 0.0135). The combined study yielded an allele frequency of 37.3 % (34.7-39.9) for Type II diabetic patients and 30.5 % (27.7-33.4) for glucose-tolerant subjects (p = 0.0007). No interaction between this variant and the Pro12Ala polymorphism of PPAR-gamma2 was observed.Conclusion/interpretation A widespread Gly482Ser polymorphism of PGC-1 is associated with a 1.34 genotype relative risk of Type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transcriptional analysis reveals that expression of PGC-1α target genes is coordinately down-regulated in human diabetics [84, 85] and PGC-1α genetic polymorphisms have been linked to Type II Diabetes [104, 105].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes
Hara, K., Okada, T., Tobe, K., Yasuda, K., Mori, Y., Kadowaki, H., Hagura, R., Akanuma, Y., Kimura, S., Ito, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2605 · Cited by 273
Hani, E. H., Boutin, P., Durand, E., Inoue, H., Permutt, M. A., Velho, G., & Froguel, P. (1998) · Diabetologia · doi:10.1007/s001250051098 · Cited by 264
Mori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.891 · Cited by 238
Cited by
Items 101–200 of 293
Myles, S., Lea, R. A., Ohashi, J., Chambers, G. K., Weiss, J., Hardouin, E. A., Engelken, J., Macartney-Coxson, D. P., Eccles, D., Naka, I., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-10 · Cited by 69
Evidence of an association between genetic variation of the coactivator PGC-1β and obesity
Andersen, G., Wegner, L., Yanagisawa, K., Rose, C. S., Lin, J. D., Glümer, C., Drivsholm, T., Borch-Johnsen, K., Jørgensen, T., Hansen, T. F., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.026278 · Cited by 58
Self-citationApplication of nutrigenomic concepts to Type 2 diabetes mellitus
Kaput, J., Noble, J. A., Hatipoğlu, B., Kari Kohrs, E., Dawson, K., & Bartholomew, A. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.11.006 · Cited by 63
Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes
Devarshi, P., McNabney, S., & Henagan, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040831 · Cited by 53
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
“serine containing variant seems fully functional [154-156].”
Kunej, T., Petrovič, M. G., Dovč, P., Peterlin, B., & Petrovič, D. (2004) · Folia Biologica · doi:10.14712/fb2004050050157 · Cited by 53
Causation of Type 2 Diabetes — The Gordian Knot Unravels
Taylor, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038239 · Cited by 53
Choi, Y.-S., Hong, J.-M., Lim, S., Ko, K. S., & Pak, Y. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.193 · Cited by 60
Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians
Vimaleswaran, K. S., Radha, V., Anjana, M., Deepa, R., Ghosh, S., Majumder, P. P., Rao, M. R. S., & Mohan, V. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803228 · Cited by 54
Oberkofler, H., Hölzl, B., Esterbauer, H., Xie, M., Iglseder, B., Krempler, F., Paulweber, B., & Patsch, W. (2003) · Hypertension · doi:10.1161/01.hyp.0000050962.48249.b7 · Cited by 59
Muscle lipid metabolism in the metabolic syndrome
Perseghin, G. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174401.07056.56 · Cited by 50
Docrat, T. F., Nagiah, S., Naicker, N., Baijnath, S., Singh, S. D., & Chuturgoon, A. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173059 · Cited by 52
Linking disease-associated genes to regulatory networks via promoter organization
hr, S. D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki230 · Cited by 48
Lane, R. H., MacLennan, N. K., Daood, M. J., Hsu, J. L., Janke, S. M., Pham, T. D., Puri, A. R., & Watchko, J. F. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000064583.40495.51 · Cited by 48
New methods for finding disease-susceptibility genes: impact and potential.
McCarthy, M. I., Smedley, D. P., & Hide, W. (2003) · Genome biology · doi:10.1186/gb-2003-4-10-119 · Cited by 53
PGC-1α Gly482Ser Polymorphism Associates With Hypertension Among Danish Whites
Andersen, G., Thørner, L. W., Jensen, D. P., Glümer, C., Tarnow, L., Drivsholm, T., Poulsen, P., Hansen, S. K., Nielsen, E.-M. D., Ek, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000158946.53289.24 · Cited by 50
Self-citationLattuada, G., Costantino, F., Caumo, A., Scifo, P., Ragogna, F., COBELLI, F. D., Maschio, A. D., Luzi, L., & Perseghin, G. (2005) · Diabetologia · doi:10.1007/s00125-005-1686-6 · Cited by 47
“It has been suggested that the molecular mechanisms behind the abnormal pattern of lipid oxidation may be linked with a common polymorphism of the PPAR-γ coactivator 1 (a transcriptional regulator of genes responsible for mitochondrial biogenesis and fat oxidation) in a Danish population [28] and in Pima Indians [29].”
BackgroundYang, Y., Mo, X., Chen, S., Lu, X., & Gu, D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1158 · Cited by 50
Patti, M.-E. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134359.23288.72 · Cited by 43
Ambye, L., Rasmussen, S. L., Fenger, M., Jørgensen, T., Borch‐Johnsen, K., Madsbad, S., & Urhammer, S. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.013 · Cited by 48
Self-citationLonard, D. M., Kumar, R., & O’Malley, B. W. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0276 · Cited by 45
Fanelli, M., Filippi, E., Sentinelli, F., Romeo, S., Fallarino, M., Buzzetti, R., Leonetti, F., & Baroni, M. G. (2005) · Disease Markers · doi:10.1155/2005/576748 · Cited by 43
Kim, J. H., Shin, H. D., Park, B. L., Cho, Y., Kim, S. Y., Lee, H. K., & Park, K. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1793-4 · Cited by 48
“05), assuming the genotype risk is similar to that of patients in a Danish study [12].”
BackgroundResultInfluentialGenetic factors related to mitochondrial function and risk of diabetes mellitus
Cho, Y. M., Park, K. S., & Lee, H. K. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.052 · Cited by 47
T2D-Db: An integrated platform to study the molecular basis of Type 2 diabetes
Agrawal, S., Dimitrova, N., Nathan, P., Udayakumar, K., Lakshmi, S. S., Sriram, S., Manjusha, N., & Sengupta, U. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-320 · Cited by 44
Genotype modulators of clinical severity in McArdle disease
Rubio‐Terres, C., Gómez‐Gallego, F., Santiago, C., García‐Consuegra, I., Pérez, M., Moro, M. I. B., Andreu, A. L., Martín, M. A., Arenas, J., & Lucía, A. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.025 · Cited by 43
San‐Millán, J. L., & Escobar-Morreale, H. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03679.x · Cited by 46
Islet b cell failure in type 2 diabetes
Prentki, M., & Nolan, C. J. (2006) · Cited by 47
PPAR-γ2 Pro12Ala Variant Is Associated with Greater Insulin Sensitivity in Childhood Obesity
Buzzetti, R., Petrone, A., Caiazzo, A. M., Alemanno, I., Zavarella, S., Capizzi, M., Mein, C. A., Osborn, J., Vania, A., & Mario, U. D. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000147728.62185.21 · Cited by 48
Horenstein, R. B., & Shuldiner, A. R. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000016122.84105.75 · Cited by 42
“The Gly482Ser variant was also reported to be associated with T2DM in a study of Danish Caucasians [72], but not in a study of French Caucasians, where power to detect an association may have been limited by relatively small numbers [73].”
ResultEk, J., Rose, C. S., Jensen, D. P., Glümer, C., Borch-Johnsen, K., Jørgensen, T., Pedersen, O., & Hansen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2159 · Cited by 38
Self-citationPGC-1?? Genotype Modifies the Association of Volitional Energy Expenditure with &OV0312;O2max
FRANKS, P. W., BARROSO, I., LUAN, J., EKELUND, U., CROWLEY, V. E. F., BRAGE, S., SANDHU, M. S., JAKES, R. W., S. MIDDELBERG, R. P., HARDING, A.-H., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000099109.73351.81 · Cited by 38
de Souza, C. T., ARAUJO, E. P. D., Prada, P. O., Saad, M. J. A., Boschero, A. C., & Velloso, L. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1866-4 · Cited by 49
“Moreover, at least two clinical series have found a correlation between mutations of the Ppargc1a (previously known as PGC-1α gene) and insulin resistance or diabetes [14, 15].”
BackgroundMechanisms and therapeutic targets in type 2 diabetes mellitus
Panunti, B. A., Jawa, A., & Fonseca, V. A. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.09.011 · Cited by 46
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
Sookoian, S. C., García, S. I., Porto, P. I., Dieuzeide, G., González, C. D., & Pirola, C. J. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01837 · Cited by 38
“Although we found no reports in the literature about pediatric populations, our findings are in accord with what Muller et al. (2003) have found in non-diabetic Pima Indians, in whom they described that the Gly482 variant is associated with a decreased insulin secretory response to i.v. and oral glucose administration.”
BackgroundInfluentialGenes and pathophysiology of type 2 diabetes: more than just the Randle cycle all over again
Shuldiner, A. R., & McLenithan, J. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23586 · Cited by 42
Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?
Burén, J., & Eriksson, J. W. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.567 · Cited by 43
“In this regard it is of great interest that a common polymorphism of the peroxisome proliferator-activated receptor-γ coactivator 1 (PGC-1), a transcriptional regulator of genes responsible for mitochondrial biogenesis and fat oxidation [98], has been linked to an increased relative risk of type 2 diabetes [99] as wel…”
BackgroundWeng, S., Lin, T., Wang, P., Chen, I., Lee, H., Chen, S., Chuang, Y., & Liou, C. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.021 · Cited by 39
Zhang, K., Huang, Q., Dai, X., Yin, J., Zhang, W., Zhou, G., Zhou, G., & Liu, Z. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009355159 · Cited by 35
“However, other studies showed that there were no association between Thr394Thr polymorphism and T2DM development in Caucasian and Japanese subjects.(12,13,18) Our results in the present study were consistent with results of a study of Japanese subjects,(18) which suggested that there was no relationship between A alle…”
ResultZhang, S., Lu, W., Yan, L., Mu-chao, W., Xu, M., Chen, L., & Cheng, H. (2007) · PubMed · Cited by 40
Vohl, M., Houde, A., Lebel, S., Hould, F., & Marceau, P. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.07.002 · Cited by 36
Steinbacher, P., Feichtinger, R. G., Kedenko, L., Kedenko, I., Reinhardt, S., Schönauer, A.-L., Leitner, I., Sänger, A. M., Stoiber, W., Kofler, B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123881 · Cited by 33
“Similarly reduced mRNA levels of skeletal muscle PGC-1α in sedentary T2D subjects have been found by Timmons et al. [29], indicating diminished substrate oxidation.”
BackgroundInfluentialStage, T. B., Christensen, M. M. H., Feddersen, S., Beck‐Nielsen, H., & Brøsen, K. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835f91fc · Cited by 34
Oberkofler, H., Hafner, M., Felder, T. K., Krempler, F., & Patsch, W. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0425-0 · Cited by 37
“A major role of PGC-1α in T2DM is further supported by animal models and human studies showing associations of SNPs and haplotypes across the PGC-1α gene locus with T2DM risk, carbohydrate metabolism, insulin sensitivity, and surrogate markers of β-cell function [4–6].”
BackgroundVimaleswaran, K. S., Luan, J., Andersen, G., Muller, Y. L., Wheeler, E., Brito, E. C., O’Rahilly, S., Pedersen, O. B., Baier, L. J., Knowler, W. C., et al. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90423.2008 · Cited by 33
“Since its initial reported association with Type 2 diabetes (7), a common missense variant at exon 8 of the peroxisome proliferator activated receptor- coactivator 1 (PPARGC1A) gene has been repeatedly associated with type 2 diabetes (4) and with related traits, including obesity (19), dyslipidemia (9), aerobic fitnes…”
Self-citationSun, L. D., Yang, Z., Jin, F., Zhu, X., Qu, Y. C., Shi, X., & Wang, L. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01949.x · Cited by 38
Wang, S., Fu, C., Wang, H., Shi, Y., Xu, X.-Q., Chen, J., Song, X., Sun, K., Wang, J., Fan, X., et al. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.189 · Cited by 32
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.034 · Cited by 36
Gallagher, C. J., Keene, K. L., Mychaleckyj, J. C., Langefeld, C. D., Hirschhorn, J. N., Henderson, B. E., Gordon, C. J., Freedman, B. I., Rich, S. S., Bowden, D. W., et al. (2007) · Diabetes · doi:10.2337/db06-0303 · Cited by 35
Johansen, A., Nielsen, E., Andersen, G., Hamid, Y. H., Jensen, D. P., Gl�mer, C., Drivsholm, T., Borch‐Johnsen, K., J�rgensen, T., Hansen, T. F., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1459-7 · Cited by 31
“Blood samples were drawn after a 12-h overnight fast and plasma glucose, serum-specific insulin levels, serum C-peptide, and HbA1c were measured using Steno Diabetes Center routine methods [17, 19].”
MethodSelf-citationWang, Y., Wu, X., Cao, Y., Yi, L., Fan, H., & Chen, J. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.047 · Cited by 31
ZHANG, S.-L., Lu, W., Yan, L., Mu-chao, W., Xu, M.-T., Li-hong, C. H. E. N., & Cheng, H. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200711010-00005 · Cited by 33
Goyenechea, E., Crujeiras, A. B., Abete, I., Parra, D., & Martínez, J. A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.011 · Cited by 32
Kaput, J., & Dawson, K. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.02.033 · Cited by 35
Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism
Vandenbeek, R., Khan, N. P., & Estall, J. L. (2017) · Endocrinology · doi:10.1210/en.2017-00872 · Cited by 40
Petrovič, M. G., Kunej, T., Peterlin, B., Dovč, P., & Petrovič, D. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.546 · Cited by 34
“The Gly482Ser polymorphism of the PPARGC1 gene has been recently associated with type 2 diabetes, body mass index, obesity and macrovascular complications of diabetes, but no study so far has addressed the microvascular complications of diabetes [14,20,23].”
BackgroundSantos, J. L., Krause, B. J., Cataldo, L. R., Vega, J. A., Salas‐Pérez, F., Mennickent, P., Gallegos, R., Milagro, F. I., Prieto-Hontoria, P. L., Riezu‐Boj, J. I., et al. (2020) · Nutrients · doi:10.3390/nu12092790 · Cited by 30
Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review
Andrade, S., Morais, T., Sandovici, I., Seabra, A. L., Constância, M., & Monteiro, M. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.681649 · Cited by 30
“and/or T2D (14, 16), which are involved in critical pathways for glucose regulatory processes, such as insulin signaling (INSR, IRS1, IRS2) (16–20), beta-cell differentiation and insulin secretion (PDX1, HNF4A, TCF7L2, SLC2A4, GLP1R, KCNQ1) (16, 17, 21–24), adipocyte differentiation (PPARG, PPARGC1A, LEP, ADIPOQ) (17,…”
BackgroundAnalysis of PGC-1α variants Gly482Ser and Thr612Met concerning their PPARγ2-coactivation function
Nitz, I., Ewert, A., Klapper, M., & Döring, F. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.042 · Cited by 29
“The PPARc2-12 variant is reported to have protective effects concerning the risk of developing insulin resistance or diabetes type 2 [6,16,20–23] but there are also studies showing no association between Pro12Ala polymorphism and prevalence of the metabolic syndrome and insulin resistance [24–26].”
BackgroundTharabenjasin, P., Pabalan, N., & Jarjanazi, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0200967 · Cited by 31
PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge
Franks, P. W., Ekelund, U., Brage, S., Luan, J., Schafer, A. J., O’Rahilly, S., Barroso, I., & Wareham, N. J. (2007) · Diabetologia · doi:10.1007/s00125-006-0580-1 · Cited by 32
“Although animal data indicate a role for PPARGC1A in lipogenesis, only one small study has thus far reported on the association between Gly482Ser and NEFA levels [6], with two other studies reporting associations between Gly482Ser and cholesterol levels [7, 8].”
Jacobs, K., Rohrer, G. A., Poucke, M. V., Piumi, F., Yerle, M., Barthenschlager, H., Mattheeuws, M., Zeveren, A. V., & Peelman, L. J. (2005) · Cytogenetic and Genome Research · doi:10.1159/000087521 · Cited by 32
“In an association study by Esterbauer et al. (2002), two polymorphisms in the human PPARGC1A gene were associated with obesity in middle-aged women and Hara et al. (2002) found an association with insulin resistance and susceptibility to type II diabetes in human (Ek et al., 2001).”
BackgroundLinkage and Association Studies of the Susceptibility Genes for Type 2 Diabetes
Huang, Q., Cheng, M., & Ji, S.-L. (2006) · Acta Genetica Sinica · doi:10.1016/s0379-4172(06)60087-5 · Cited by 34
Chen, S., Yan, W., Huang, J., Yang, W., & Gu, D. (2004) · Hypertension Research · doi:10.1291/hypres.27.813 · Cited by 29
Kružliak, P., Haley, A. P., Starčević, J. N., Gašpar, Ľ., & Petrovič, D. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0197-0 · Cited by 27
“These findings differ from an early report in the Slovene population from 2004 [28] and from the report from another Caucasian population [18], in which the authors reported a link”
InfluentialIs there an association between PPARGC1A genotypes and endurance capacity in Chinese men?
He, Z., Hu, Y., Feng, L., Bao, D., Wang, L., Li, Y., Wang, J., Liu, G., Xi, Y., Li, W., et al. (2007) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2007.00648.x · Cited by 33
“The Ser482 allele has also been associated with lower muscle levels of PPARCG1A mRNA in healthy older Danish individuals (Ling et al., 2004).”
ResultAndersen, G., Rose, C. S., Hamid, Y. H., Drivsholm, T., Borch‐Johnsen, K., Hansen, T. F., & Pedersen, O. B. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2445 · Cited by 29
“PCR amplification was carried out as described (15) with primer sequences, MgCl2 concentration, and annealing temperatures as listed in Table 3.”
MethodSelf-citationPihlajamäki, J., Alanne-Kinnunen, M., Ruotsalainen, E., Salmenniemi, U., Vauhkonen, I., Kuulasmaa, T., Kainulainen, S., & Laakso, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1800-9 · Cited by 27
“In previous studies the Gly482Ser polymorphism and the silent polymorphisms Thr394Thr and Asp475Asp of PPARGC1A have been associated with type 2 diabetes [2, 3].”
BackgroundASSOCIATION BETWEEN PPARGC1A GENE POLYMORPHISMS AND CORONARY ARTERY DISEASE IN A CHINESE POPULATION
Zhang, Y., Xu, W., Li, X., Tang, Y., Xie, P., Ji, Y. I., Fan, L., & Chen, Q. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04988.x · Cited by 28
“The downstream primer was 5-CTTGCCTCCAAAGTCTCTC-3.(16) The PCR amplification was performed in a PTC200 Peltier thermal cycler (MJ Research, Watertown, MA, USA).”
MethodZhu, L., Huang, Q., Xie, Z., Kang, M., Ding, H., Chen, B., Chen, Y., Liu, C., Wang, Y., & Tang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.16307 · Cited by 29
“Previous study suggested that PPARGC1A rs3736265 G>A polymorphism was associated with the decreased risk of T2DM in a Danish population, and the PPARGC1A rs3736265A allele might be a protective factor in T2DM [33].”
BackgroundStorgaard, H., Poulsen, P., Ling, C., Groop, L., & Vaag, A. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1172 · Cited by 27
Cheurfa, N., Reis, A. F., Dubois‐Laforgue, D., Bellanné‐Chantelot, C., Timsit, J., & Velho, G. (2004) · Diabetologia · doi:10.1007/s00125-004-1567-4 · Cited by 26
β-Cell Mitochondrial Dysfunction: Underlying Mechanisms and Potential Therapeutic Strategies
Darwish, R., Alcibahy, Y., Abu-Sharia, G., & Butler, A. E. (2025) · Cells · doi:10.3390/cells14231861 · Cited by 26
Ramos-López, O., Riezu‐Boj, J. I., Milagro, F. I., Goñi, L., Cuervo, M., & Martínez, J. A. (2018) · Nutrition · doi:10.1016/j.nut.2017.10.008 · Cited by 27
Maciejewska, A., Massidda, M., Tocco, F., & Leźnicka, K. (2022) · Nutrients · doi:10.3390/nu14245378 · Cited by 25
Mercado, M. V.-D., Guzmán-Ornelas, M.-O., Corona-Meraz, F.-I., Ríos-Ibarra, C. P., Reyes‐Serratos, E., Castro-Albarrán, J., Ruíz-Quezada, S. L., & Navarro-Hernández, R. E. (2015) · BioMed Research International · doi:10.1155/2015/285491 · Cited by 23
“In PPARGC1A, a polymorphism that consists in a transition at codon 482 (rs8192678) was associated with chronic diseases [8–13].”
BackgroundGawęda-Walerych, K., & Żekanowski, C. (2014) · Current Genomics · doi:10.2174/1389202914666131210211033 · Cited by 29
Okauchi, Y., Iwahashi, H., Okita, K., Yuan, M., Matsuda, M., Tanaka, T., Miyagawa, J., Funahashi, T., Horikawa, Y., Shimomura, I., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-070 · Cited by 28
Brito, E. C., Vimaleswaran, K. S., Brage, S., Andersen, L. B., Sardinha, L. B., Wareham, N. J., Ekelund, U., Loos, R. J. F., & Franks, P. W. (2009) · Diabetologia · doi:10.1007/s00125-009-1269-z · Cited by 29
“Associations between Gly482Ser and type 2 diabetes [2, 3], hypertension [4], obesity [5], dyslipidaemia [6–8], aerobic fitness [9] and insulin resistance [10] have been widely reported.”
BackgroundZhu, S., Liu, Y., Wang, X., Wu, X., Zhu, X., Li, J., Ma, J., Gu, H. F., & Liu, Y. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.020 · Cited by 21
TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse
Bernardi, S., Toffoli, B., Tisato, V., Bossi, F., Biffi, S., Lorenzon, A., Zauli, G., Secchiero, P., & Fabris, B. (2017) · Clinical Science · doi:10.1042/cs20171221 · Cited by 21
“Interestingly, PGC-1α polymorphisms have been associated with obesity and increased 356 risk of diabetes (43, 44).”
BackgroundLing, C., Wegner, L., Andersen, G., Almgren, P.-E., Hansen, T. F., Pedersen, O. B., Groop, L., Vaag, A. A., & Poulsen, P. (2007) · Diabetologia · doi:10.1007/s00125-007-0729-6 · Cited by 21
“We originally showed that a common variant in the PGC-1α gene, Gly482Ser, is associated with increased risk of type 2 diabetes mellitus as well as with altered lipid and glucose metabolism [4].”
BackgroundSelf-citationNuclear Receptor Co-regulators
Lonard, D. M., & O’Malley, B. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00024-7 · Cited by 21
Chae, S. J., Kim, J., Choi, Y. M., Kim, J. M., Cho, Y. M., & Moon, S. Y. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000279309 · Cited by 20
Gene expression in the pathophysiology of type 2 diabetes mellitus
Patti, M. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0020-x · Cited by 22
The PPARGC1AGly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men
Ingelsson, E., Bennet, L., Ridderstråle, M., Söderström, M., Råstam, L., & Lindblad, U. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-37 · Cited by 25
“This contrasts with prior findings that the Ser allele is associated with higher risk of diabetes, [11-13], but agrees with findings that it is associated with lower risk of hypertension, [15,16] both of which are major risk factors Table 3: Associations between the PGC1α Gly482Ser polymorphism and diastolic dysfuncti…”
Xia, W., Chen, N., Peng, W., Jia, X., Yu, Y., Wu, X., & Gao, H. (2019) · Disease Markers · doi:10.1155/2019/2970401 · Cited by 19
Epigenetic Manifestation of Metabolic Syndrome and Dietary Management
Chaudhary, N., Nakka, K. K., Maulik, N., & Chattopadhyay, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4387 · Cited by 22
“Furthermore, in the PPARGC1A gene, a common polymorphism at Gly482 Ser has been found to be responsible for increased risk of T2D in an age-dependent manner (22, 92, 194).”
Totomoch-Serra, A., Muñoz, M. D. L., Burgueño, J. A., Revilla, M., & Díaz-Badillo, Á. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.74757 · Cited by 18
“PPARGC1A (rs8192678) has been associated with T2D in populations from Denmark and northern China [9, 10], and the UCP2 (rs659366) gene has been associated with T2D and diabetic retinopathy in Shanghai, China [11].”
BackgroundCheema, A. K., Li, T., Liuzzi, J. P., Zarini, G. G., Dorak, M. T., & Huffman, F. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/921274 · Cited by 20
Reiling, E., van Vliet‐Ostaptchouk, J. V., Riet, E. V. ‘., van Haeften, T. W., Arp, P., Hansen, T. F., Kremer, D., Groenewoud, M. J., van Hove, E. C., Romijn, J. A., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.4 · Cited by 18
Self-citationRole of Peroxisome Proliferator-Activated Receptor Gamma in Glucose-induced Insulin Secretion
Xu, Z.-K., Chen, N.-G., Ma, C.-Y., Meng, Z., Sun, Y.-J., & Han, X. Q. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00128.x · Cited by 18
Shokouhi, S., Haghani, K., Borji, P., & Bakhtiyari, S. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.05.003 · Cited by 17
Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics
Hawkins, L. J., Al-attar, R., & Storey, K. B. (2018) · PeerJ · doi:10.7717/peerj.5062 · Cited by 21
“In another case, dysregulation in PGC-1a, a coactivator of PPAR and PPARa which are involved in adipogenesis and mitochondrial fatty acid oxidation respectively, was shown to increase the risk of type II diabetes (Ek et al., 2001).”
BackgroundEstrogen-related receptor α (ERRα): A novel target in type 2 diabetes
Handschin, C., & Mootha, V. K. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.001 · Cited by 24
Mirzaei, K., Hossein‐Nezhad, A., Emamgholipour, S., Ansar, H., Khosrofar, M., Tootee, A., & Alatab, S. (2012) · Lifestyle Genomics · doi:10.1159/000337352 · Cited by 23
Leipold, H., Knöefler, M., Gruber, C. J., Huber, A., Haslinger, P., & Worda, C. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.12.004 · Cited by 16
Relationship of PGC-1α Gene Polymorphism With Insulin Resistance Syndrome in Korean Children
Ha, C., Cho, J., Han, T., Lee, S., & Kang, H. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513477685 · Cited by 19
Kong, X., Fan, H., Liu, X., Wang, R., Liang, J., Gupta, N., Chen, Y., Fang, F., & Chang, Y. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056424 · Cited by 16
“Its dysregulation is associated with the insulin resistance and mitochondrial dysfunction in type 2 diabetic patients (Ek et al., 2001; Andrulionytè et al., 2004).”
Metadata
- Authors
- Ek, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O.
- Affiliations
- Glostrup Hospital (DK)
- Venue
- Diabetologia
- Published
- 2001-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 2220-2226
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1984668213
- Cited by
- 293
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 3 · 2015: 11 · 2014: 7 · 2013: 12 · 2012: 15
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- Velux Stiftung
- Hjerteforeningen
- Sundhed og Sygdom, Det Frie Forskningsråd
- Diabetesforeningen
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PGC-1, type 2 diabetes, Gly482Ser polymorphism, genetic association, genotype relative risk, amino acid polymorphism, genetic susceptibility to diabetes
- MeSH terms
- Aged, Alleles, Amino Acid Sequence, Diabetes Mellitus, Type 2, DNA Mutational Analysis, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Transcription Factors, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.